Abstract S102 Table 1
Final clinical diagnosisNo. of casesLymphocytes, % of total cellsLymphocyte CD4:CD8 ratioNeutrophils, % of total cells
Pulmonary sarcoidosis2126 (16.5–43.3)4 (2.8–9.5)3 (2.5–6)
Bacterial infection/pneumonia1811 (5.5–29)0.6 (0.4–1.4)15 (8–30)
Tuberculosis1351 (30–61)1 (0.2–2.8)3 (1–9)
Pneumocystis jirovecii pneumonia615 (13–19)0 (0–0.3)8 (4–24)
Non-tuberculous mycobacteria521 (14–23)3 (2–5.7)12 (3–33)
Other interstitial lung disease48 (5.5–35.1)0 (0.1–0.5)21 (12–25)
Mediastinal lymph node sarcoidosis410 (4–17.8)1 (1–1.3)8 (6–25)
Extrathoracic sarcoidosis316 (14.9–35.4)1 (1–1.3)8 (6–25)
Fungal pneumonia38 (8–8)1 (0.61–0.65)4 (3–5.5)
Bronchiectasis33 (2.5–4)0 (0.2–1.8)14 (10.5–17.5)
Unknown249 (4.3–15.5)2 (0.8–2.1)11 (5.3–21.8)